Form 4 for ABT Abbott Laboratories
Accepted 2022-06-07 00:00:00 ET · period of report 2022-06-03 · accession 0001415889-22-006223 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-07 | 2022-06-03 | ABT | Ginascol John F | EVP | F - Tax | $117.51 | -1,768 | 122.9K | -1% | -$207.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2022-06-03 | F | D | 1,768 | $117.51 | 122,912 | D | — | — |